Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Satellite-Based Assessment of Grassland Conversion and Related Fire Disturbance in the Kenai Peninsula, Alaska.

Hess KA, Cullen C, Cobian-Iñiguez J, Lenske V, Ramthun JS, Magness DR, Bolten JD, Foster AC, Spruce J.

Remote Sens (Basel). 2019;11(3). doi: 10.3390/rs11030283. Epub 2019 Feb 1.

2.

BDNF, NT-3 and Trk receptor agonist monoclonal antibodies promote neuron survival, neurite extension, and synapse restoration in rat cochlea ex vivo models relevant for hidden hearing loss.

Szobota S, Mathur PD, Siegel S, Black K, Saragovi HU, Foster AC.

PLoS One. 2019 Oct 31;14(10):e0224022. doi: 10.1371/journal.pone.0224022. eCollection 2019.

3.

Inhibitors of the Neutral Amino Acid Transporters ASCT1 and ASCT2 Are Effective in In Vivo Models of Schizophrenia and Visual Dysfunction.

Li YX, Yang JY, Alcantara M, Abelian G, Kulkarni A, Staubli U, Foster AC.

J Pharmacol Exp Ther. 2018 Nov;367(2):292-301. doi: 10.1124/jpet.118.251116. Epub 2018 Aug 31.

PMID:
30171039
4.

Secure communications using nonlinear silicon photonic keys.

Grubel BC, Bosworth BT, Kossey MR, Cooper AB, Foster MA, Foster AC.

Opt Express. 2018 Feb 19;26(4):4710-4722. doi: 10.1364/OE.26.004710.

PMID:
29475318
5.

Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.

Brioude F, Kalish JM, Mussa A, Foster AC, Bliek J, Ferrero GB, Boonen SE, Cole T, Baker R, Bertoletti M, Cocchi G, Coze C, De Pellegrin M, Hussain K, Ibrahim A, Kilby MD, Krajewska-Walasek M, Kratz CP, Ladusans EJ, Lapunzina P, Le Bouc Y, Maas SM, Macdonald F, Õunap K, Peruzzi L, Rossignol S, Russo S, Shipster C, Skórka A, Tatton-Brown K, Tenorio J, Tortora C, Grønskov K, Netchine I, Hennekam RC, Prawitt D, Tümer Z, Eggermann T, Mackay DJG, Riccio A, Maher ER.

Nat Rev Endocrinol. 2018 Apr;14(4):229-249. doi: 10.1038/nrendo.2017.166. Epub 2018 Jan 29. Review.

6.

Pump-degenerate phase-sensitive amplification in amorphous silicon waveguides.

Sun H, Wang KY, Foster AC.

Opt Lett. 2017 Sep 15;42(18):3590-3593. doi: 10.1364/OL.42.003590.

PMID:
28914909
7.

Phenylglycine analogs are inhibitors of the neutral amino acid transporters ASCT1 and ASCT2 and enhance NMDA receptor-mediated LTP in rat visual cortex slices.

Foster AC, Rangel-Diaz N, Staubli U, Yang JY, Penjwini M, Viswanath V, Li YX.

Neuropharmacology. 2017 Nov;126:70-83. doi: 10.1016/j.neuropharm.2017.08.010. Epub 2017 Aug 12.

PMID:
28807674
8.

Silicon photonic physical unclonable function.

Grubel BC, Bosworth BT, Kossey MR, Sun H, Cooper AB, Foster MA, Foster AC.

Opt Express. 2017 May 29;25(11):12710-12721. doi: 10.1364/OE.25.012710.

PMID:
28786625
9.

Wavelength multicasting through four-wave mixing with an optical comb source.

Ting HF, Wang KY, Stroud JR, Petrillo KG, Sun H, Foster AC, Foster MA.

Opt Express. 2017 Apr 17;25(8):9276-9284. doi: 10.1364/OE.25.009276.

PMID:
28438003
10.

Four-wave mixing Bragg scattering in hydrogenated amorphous silicon waveguides.

Li K, Sun H, Foster AC.

Opt Lett. 2017 Apr 15;42(8):1488-1491. doi: 10.1364/OL.42.001488.

PMID:
28409779
11.

Restoration of visual performance by d-serine in models of inner and outer retinal dysfunction assessed using sweep VEP measurements in the conscious rat and rabbit.

Staubli U, Rangel-Diaz N, Alcantara M, Li YX, Yang JY, Zhang KM, Foster AC.

Vision Res. 2016 Oct;127:35-48. doi: 10.1016/j.visres.2016.07.005. Epub 2016 Jul 27.

12.

High-speed all-optical NAND/AND logic gates using four-wave mixing Bragg scattering.

Li K, Ting HF, Foster MA, Foster AC.

Opt Lett. 2016 Jul 15;41(14):3320-3. doi: 10.1364/OL.41.003320.

PMID:
27420525
13.

D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures.

Foster AC, Farnsworth J, Lind GE, Li YX, Yang JY, Dang V, Penjwini M, Viswanath V, Staubli U, Kavanaugh MP.

PLoS One. 2016 Jun 7;11(6):e0156551. doi: 10.1371/journal.pone.0156551. eCollection 2016.

14.

Activity of the enantiomers of erythro-3-hydroxyaspartate at glutamate transporters and NMDA receptors.

Foster AC, Li YX, Runyan S, Dinh T, Venadas S, Chen J, Pashikanti S, Datta A, Ehring G, Staubli U.

J Neurochem. 2016 Feb;136(4):692-697. doi: 10.1111/jnc.13430. Epub 2015 Dec 18.

15.

Wavelength-agile near-IR optical parametric oscillator using a deposited silicon waveguide.

Wang KY, Foster MA, Foster AC.

Opt Express. 2015 Jun 15;23(12):15431-9. doi: 10.1364/OE.23.015431.

PMID:
26193523
16.

Effects of 3-aminoglutarate, a "silent" false transmitter for glutamate neurons, on synaptic transmission and epileptiform activity.

Wu Z, Foster AC, Staubli U, Wu X, Sun C, Tang X, Li YX, Chen G.

Neuropharmacology. 2015 Oct;97:95-103. doi: 10.1016/j.neuropharm.2015.05.011. Epub 2015 May 19.

PMID:
26002626
17.

3-Aminoglutarate is a "silent" false transmitter for glutamate neurons.

Foster AC, Chen J, Runyan S, Dinh T, Venadas S, Ehring GR, Li YX, Staubli U.

Neuropharmacology. 2015 Oct;97:436-46. doi: 10.1016/j.neuropharm.2015.05.010. Epub 2015 May 19.

PMID:
26002625
18.

Commentary on Muscle dysmorphia as an addiction: a response to Grant (2015) and Nieuwoudt (2015).

Griffiths MD, Foster AC, Shorter GW.

J Behav Addict. 2015 Mar;4(1):11-3. doi: 10.1556/JBA.4.2015.1.4.

19.

Muscle dysmorphia: could it be classified as an addiction to body image?

Foster AC, Shorter GW, Griffiths MD.

J Behav Addict. 2015 Mar;4(1):1-5. doi: 10.1556/JBA.3.2014.001. Review.

20.

Non-instantaneous optical nonlinearity of an a-Si:H nanowire waveguide.

Wathen JJ, Pagán VR, Suess RJ, Wang KY, Foster AC, Murphy TE.

Opt Express. 2014 Sep 22;22(19):22730-42. doi: 10.1364/OE.22.022730.

PMID:
25321742
21.

Multichannel photon-pair generation using hydrogenated amorphous silicon waveguides.

Wang KY, Velev VG, Lee KF, Kowligy AS, Kumar P, Foster MA, Foster AC, Huang YP.

Opt Lett. 2014 Feb 15;39(4):914-7. doi: 10.1364/OL.39.000914.

PMID:
24562240
22.

Highly sensitive ultrafast pulse characterization using hydrogenated amorphous silicon waveguides.

Petrillo KG, Wang KY, Foster AC, Foster MA.

Opt Express. 2013 Dec 16;21(25):31229-38. doi: 10.1364/OE.21.031229.

PMID:
24514697
23.

Ultralow-power all-optical processing of high-speed data signals in deposited silicon waveguides.

Wang KY, Petrillo KG, Foster MA, Foster AC.

Opt Express. 2012 Oct 22;20(22):24600-6. doi: 10.1364/OE.20.024600.

PMID:
23187222
24.

Waveguide-fed optical hybrid plasmonic patch nano-antenna.

Yousefi L, Foster AC.

Opt Express. 2012 Jul 30;20(16):18326-35. doi: 10.1364/OE.20.018326.

PMID:
23038383
25.

Ultralow power continuous-wave frequency conversion in hydrogenated amorphous silicon waveguides.

Wang KY, Foster AC.

Opt Lett. 2012 Apr 15;37(8):1331-3. doi: 10.1364/OL.37.001331.

PMID:
22513676
26.

Infant oral mutilation: a New Zealand case series.

de Beavis FO, Foster AC, Fuge KN, Whyman RA.

N Z Dent J. 2011 Jun;107(2):57-9.

PMID:
21721338
27.

Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.

Dyck B, Tamiya J, Jovic F, Pick RR, Bradbury MJ, O'Brien J, Wen J, Johns M, Madan A, Fleck BA, Foster AC, Li B, Zhang M, Tran JA, Vickers T, Grey J, Saunders J, Chen C.

J Med Chem. 2008 Nov 27;51(22):7265-72. doi: 10.1021/jm8009537.

PMID:
18954038
28.

Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.

Zhang M, Jovic F, Vickers T, Dyck B, Tamiya J, Grey J, Tran JA, Fleck BA, Pick R, Foster AC, Chen C.

Bioorg Med Chem Lett. 2008 Jul 1;18(13):3682-6. doi: 10.1016/j.bmcl.2008.05.077. Epub 2008 May 23.

PMID:
18539031
29.

Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.

Vickers T, Dyck B, Tamiya J, Zhang M, Jovic F, Grey J, Fleck BA, Aparicio A, Johns M, Jin L, Tang H, Foster AC, Chen C.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3230-5. doi: 10.1016/j.bmcl.2008.04.045. Epub 2008 Apr 25.

PMID:
18468895
30.

Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.

Tamiya J, Dyck B, Zhang M, Phan K, Fleck BA, Aparicio A, Jovic F, Tran JA, Vickers T, Grey J, Foster AC, Chen C.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3328-32. doi: 10.1016/j.bmcl.2008.04.025. Epub 2008 Apr 15.

PMID:
18445525
31.

Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.

Chen C, Tucci FC, Jiang W, Tran JA, Fleck BA, Hoare SR, Wen J, Chen T, Johns M, Markison S, Foster AC, Marinkovic D, Chen CW, Arellano M, Harman J, Saunders J, Bozigian H, Marks D.

Bioorg Med Chem. 2008 May 15;16(10):5606-18. doi: 10.1016/j.bmc.2008.03.072. Epub 2008 Apr 1.

PMID:
18417348
32.

Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.

Tran JA, Tucci FC, Arellano M, Jiang W, Chen CW, Marinkovic D, Fleck BA, Wen J, Foster AC, Chen C.

Bioorg Med Chem Lett. 2008 Mar 15;18(6):1931-8. doi: 10.1016/j.bmcl.2008.01.125. Epub 2008 Feb 7.

PMID:
18294847
33.

Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.

Chen C, Dyck B, Fleck BA, Foster AC, Grey J, Jovic F, Mesleh M, Phan K, Tamiya J, Vickers T, Zhang M.

Bioorg Med Chem Lett. 2008 Feb 15;18(4):1346-9. doi: 10.1016/j.bmcl.2008.01.011. Epub 2008 Jan 9.

PMID:
18207394
34.

Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.

Chen C, Jiang W, Tran JA, Tucci FC, Fleck BA, Markison S, Wen J, Madan A, Hoare SR, Foster AC, Marinkovic D, Chen CW, Arellano M, Saunders J.

Bioorg Med Chem Lett. 2008 Jan 1;18(1):129-36. Epub 2007 Nov 4.

PMID:
18032040
35.

Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptor.

Tran JA, Jiang W, Tucci FC, Fleck BA, Wen J, Sai Y, Madan A, Chen TK, Markison S, Foster AC, Hoare SR, Marks D, Harman J, Chen CW, Arellano M, Marinkovic D, Bozigian H, Saunders J, Chen C.

J Med Chem. 2007 Dec 13;50(25):6356-66. Epub 2007 Nov 10.

PMID:
17994683
36.

Synthesis and characterization of pyrrolidine derivatives as potent agonists of the human melanocortin-4 receptor.

Jiang W, Tran JA, Tucci FC, Fleck BA, Hoare SR, Markison S, Wen J, Chen CW, Marinkovic D, Arellano M, Foster AC, Chen C.

Bioorg Med Chem Lett. 2007 Dec 1;17(23):6546-52. Epub 2007 Oct 22.

PMID:
17933528
37.

Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia.

Chen C, Jiang W, Tucci F, Tran JA, Fleck BA, Hoare SR, Joppa M, Markison S, Wen J, Sai Y, Johns M, Madan A, Chen T, Chen CW, Marinkovic D, Arellano M, Saunders J, Foster AC.

J Med Chem. 2007 Nov 1;50(22):5249-52. Epub 2007 Oct 5.

PMID:
17918824
38.

Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor.

Jiang W, Tucci FC, Tran JA, Fleck BA, Wen J, Markison S, Marinkovic D, Chen CW, Arellano M, Hoare SR, Johns M, Foster AC, Saunders J, Chen C.

Bioorg Med Chem Lett. 2007 Oct 15;17(20):5610-3. Epub 2007 Aug 23.

PMID:
17822895
39.

Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice.

Cheung WW, Kuo HJ, Markison S, Chen C, Foster AC, Marks DL, Mak RH.

J Am Soc Nephrol. 2007 Sep;18(9):2517-24. Epub 2007 Aug 8.

40.

Melanocortin-4 receptor antagonists as potential therapeutics in the treatment of cachexia.

Foster AC, Chen C.

Curr Top Med Chem. 2007;7(11):1131-6. Review.

PMID:
17584133
41.

Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activity.

Tran JA, Tucci FC, Jiang W, Marinkovic D, Chen CW, Arellano M, Markison S, Fleck BA, Wen J, White NS, Pontillo J, Saunders J, Marks D, Hoare SR, Madan A, Foster AC, Chen C.

Bioorg Med Chem. 2007 Aug 1;15(15):5166-76. Epub 2007 May 17.

PMID:
17544282
42.

High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response.

Ising M, Zimmermann US, Künzel HE, Uhr M, Foster AC, Learned-Coughlin SM, Holsboer F, Grigoriadis DE.

Neuropsychopharmacology. 2007 Sep;32(9):1941-9. Epub 2007 Feb 7.

43.
44.
45.

Propionylpiperazines as human melanocortin-4 receptor ligands.

Chen CW, Tran JA, Jiang W, Tucci FC, Arellano M, Wen J, Fleck BA, Marinkovic D, White NS, Pontillo J, Saunders J, Madan A, Foster AC, Chen C.

Bioorg Med Chem Lett. 2006 Sep 15;16(18):4800-3. Epub 2006 Jul 7.

PMID:
16824757
46.

Arylpropionylpiperazines as antagonists of the human melanocortin-4 receptor.

Jiang W, Tucci FC, Chen CW, Arellano M, Tran JA, White NS, Marinkovic D, Pontillo J, Fleck BA, Wen J, Saunders J, Madan A, Foster AC, Chen C.

Bioorg Med Chem Lett. 2006 Sep 1;16(17):4674-8. Epub 2006 Jun 13.

PMID:
16777413
47.

A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phosphorylation.

Selkirk JV, Nottebaum LM, Ford IC, Santos M, Malany S, Foster AC, Lechner SM.

J Biomol Screen. 2006 Jun;11(4):351-8. Epub 2006 Apr 28.

PMID:
16751331
48.

Design, synthesis, and SAR studies on a series of 2-pyridinylpiperazines as potent antagonists of the melanocortin-4 receptor.

Tran JA, Pontillo J, Fleck BA, Marinkovic D, Arellano M, Tucci FC, Lanier M, Saunders J, Jiang W, Chen CW, Foster AC, Chen C.

Bioorg Med Chem Lett. 2006 Jul 15;16(14):3693-6. Epub 2006 May 11.

PMID:
16697187
49.

Gene expression analyses reveal molecular relationships among 20 regions of the human CNS.

Roth RB, Hevezi P, Lee J, Willhite D, Lechner SM, Foster AC, Zlotnik A.

Neurogenetics. 2006 May;7(2):67-80. Epub 2006 Mar 30.

PMID:
16572319
50.

A photometric redshift of z = 6.39 +/- 0.12 for GRB 050904.

Haislip JB, Nysewander MC, Reichart DE, Levan A, Tanvir N, Cenko SB, Fox DB, Price PA, Castro-Tirado AJ, Gorosabel J, Evans CR, Figueredo E, MacLeod CL, Kirschbrown JR, Jelinek M, Guziy S, de Ugarte Postigo A, Cypriano ES, LaCluyze A, Graham J, Priddey R, Chapman R, Rhoads J, Fruchter AS, Lamb DQ, Kouveliotou C, Wijers RA, Bayliss MB, Schmidt BP, Soderberg AM, Kulkarni SR, Harrison FA, Moon DS, Gal-Yam A, Kasliwal MM, Hudec R, Vitek S, Kubanek P, Crain JA, Foster AC, Clemens JC, Bartelme JW, Canterna R, Hartmann DH, Henden AA, Klose S, Park HS, Williams GG, Rol E, O'Brien P, Bersier D, Prada F, Pizarro S, Maturana D, Ugarte P, Alvarez A, Fernandez AJ, Jarvis MJ, Moles M, Alfaro E, Ivarsen KM, Kumar ND, Mack CE, Zdarowicz CM, Gehrels N, Barthelmy S, Burrows DN.

Nature. 2006 Mar 9;440(7081):181-3.

PMID:
16525465

Supplemental Content

Loading ...
Support Center